test

Nathalie Auber

@Sofinnova Investments, Inc.

Latest period2024 - Q3ReportedManaged Assets$1.26BTotal holdings58
Assets growth rate-34.51%Assets growth rate (2-Q avg)-13.66%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Sofinnova Investments, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 58 positions.

Assets under management

The assets under management (AUM) of Sofinnova Investments, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.26B in assets, with a quarterly growth rate of -34.51% and a 2-quarter average growth rate of -13.66%. The portfolio is managed by Nathalie Auber, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SNDXSyndax Pharmaceuticals Inc
Recent Activity
Decreased -63.45%
1.21%
$15.15M
786,999 shares@ $19.26 avg price
RYTMRhythm Pharmaceuticals
Recent Activity
New Position
1.16%
$14.495M
276,678 shares@ $52.39 avg price
EWEdwards Lifesciences Corp
Recent Activity
Decreased -83.42%
1.07%
$13.389M
202,898 shares@ $65.99 avg price
BSXBoston Scientific Corp
Recent Activity
Decreased -20.61%
0.91%
$11.382M
135,819 shares@ $83.8 avg price
PHVSPharvaris N V
Recent Activity
Decreased -0.2%
0.89%
$11.118M
600,302 shares@ $18.52 avg price
EWTXEdgewise Therapeutics Inc
Recent Activity
Decreased -19.11%
0.82%
$10.269M
384,767 shares@ $26.69 avg price
IMNMImmunome Inc
Recent Activity
Increased 3.22%
0.79%
$9.894M
676,766 shares@ $14.63 avg price
GHGuardant Health Inc
Recent Activity
New Position
0.75%
$9.328M
406,645 shares@ $22.94 avg price
RVMDRevolution Medicines Inc
Recent Activity
Decreased -55.33%
0.74%
$9.218M
203,271 shares@ $45.36 avg price
INBXInhibrx Biosciences Inc
Recent Activity
Increased 15.71%
0.67%
$8.395M
536,068 shares@ $15.67 avg price